Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Edith Perez

Hematology & Oncology Jacksonville, FL Medical Doctor

NPI 1861481590 CMS profile 129933

4500 San Pablo Rd S, Jacksonville, FL 32224

Open in the dashboard

General payments

$1,064,509

211 records reported · program years 2019–2025

Research payments

$5,270

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$150,000

3 holdings reported · through program year 2025

Through program year 2025, Edith Perez of Jacksonville, FL is reported in the CMS Open Payments database as having received $1,064,509 across 211 general payments and $5,270 in research payments paid to them. They also declared ownership or investment interests valued at $150,000 across 3 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Hematology & Oncology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $819,214 51
2024 General $53,219 20
2023 General $37,659 11
2022 General $12,809 10
2021 General $4,515 6
2021 Research $5,270 1
2020 General $71,513 22
2019 General $65,581 91
2025 Ownership $50,000 1
2024 Ownership $50,000 1
2023 Ownership $50,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Edith Perez
  • Hematology & Oncology median
  • Middle half of Hematology & Oncology
  • National median

In program year 2025, general payments to Edith Perez were reported at $819,214. Among 8,769 Hematology & Oncology profiles paid that year, the median was $683 and the middle half received between $143 and $3,154.

Show as a table
Year Edith Perez Hematology & Oncology median Middle half National median
2019 $65,581 $529 $121–$2,516 $163
2020 $71,513 $339 $82–$2,213 $114
2021 $4,515 $263 $49–$1,965 $132
2022 $12,809 $416 $103–$2,395 $149
2023 $37,659 $542 $125–$2,646 $160
2024 $53,219 $692 $141–$3,008 $164
2025 $819,214 $683 $143–$3,154 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Cornerstone Specialty Network LLC $879,136 56 payments
  2. Daiichi Sankyo Inc. $54,151 22 payments
  3. Genentech, Inc. $50,464 39 payments
  4. Puma Biotechnology, Inc. $39,927 35 payments
  5. Seattle Genetics, Inc. $14,964 18 payments
  6. Genentech USA, Inc. $11,190 13 payments
  7. AbbVie, Inc. $8,467 16 payments
  8. F. Hoffmann-La Roche AG $2,542 3 payments
  9. Samsung Bioepis Co., Ltd. $1,725 2 payments
  10. Caris MPI, Inc. $1,650 1 payment
  11. Other $294 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $505,377 41 payments
  2. Honoraria $431,749 24 payments
  3. Compensation for serving as faculty or as a speaker for a medical education program $42,814 4 payments
  4. Travel and Lodging $38,021 55 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $37,305 9 payments
  6. Food and Beverage $9,232 77 payments
  7. Education $12 1 payment
Products named General payments · program years 2019–2025
  1. ENHERTU $53,120 20 payments
  2. NERLYNX $39,927 35 payments
  3. Venclexta $8,467 16 payments
  4. Kadcyla $2,542 3 payments
  5. ONTRUZANT $1,150 1 payment
  6. Acuvue $78 2 payments
  7. Non-Covered Product $59 1 payment
  8. Esbriet $49 1 payment
  9. TECENTRIQ $48 1 payment
  10. Udenyca $39 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. F. Hoffmann-La Roche AG $5,270 1 payment

Records

212 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hematology & Oncology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record